NDAPERIARTICULARSOLUTION, EXTENDED RELEASEPriority Review
Approved
May 2021
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Loss of Exclusivity
LOE Date
Apr 21, 2036
123 months away
Patent Expiry
Apr 21, 2036
Exclusivity Expiry
Jan 23, 2027